Evidence map›Paper›PMID 42074347›Full record

ArticleInternational journal of molecular sciences2026

Correction: Liu et al. LIM Mineralization Protein-1 Inhibits the Malignant Phenotypes of Human Osteosarcoma Cells.

Huiwen Liu, Lu Huang, Zhongzu Zhang, Zhanming Zhang, Zhiming Yu, Xiang Chen, Zhuo Chen, Yongping Zen, Dong Yang, Zhimin Han and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Huiwen LiuDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Lu HuangDepartment of Children Health and Care, Jiangxi Maternal and Child Health Hospital, Nanchang 330006, China.
Zhongzu ZhangDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.ORCID 0000-0002-1382-8224
Zhanming ZhangDepartment of Oncology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhiming YuDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Xiang ChenDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhuo ChenDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Yongping ZenDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Dong YangDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhimin HanDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Yong ShuDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Min DaiDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Kai CaoDepartment of Orthopedics, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the originally published article [...].

Identifiers

PMID42074347
PMCPMC13116433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.